Expression of claudin 10 protein in hepatocellular carcinoma: Impact on survival

Journal of Cancer Research and Clinical Oncology

Volumn 137, Issue 8, 2011, Pages 1213-1218

  Huang, G W ^a   Ding, X ^a   Chen, S L ^b   Zeng, L ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b HUNAN CANCER HOSPITAL   (China)

Author keywords

Claudin 10; Hepatocellular carcinoma; Prognosis

Indexed keywords

CLAUDIN; CLAUDIN 10; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER SURVIVAL; CELL DENSITY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TISSUE SECTION; WESTERN BLOTTING;

ADULT; AGED; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; LIVER; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; MICROCIRCULATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION;

EID: 79961171251     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-0987-z     Document Type: Article

References (24)

1. MA Aldred Y Huang S Liyanarachchi NS Pellegata O Gimm S Jhiang RV Davuluri A de la Chapelle C Eng 2004 Papillary and follicular thyroid carcinomas show distinctly different microarray expression profiles and can be distinguished by a minimum of five genes J Clin Oncol 22 17 3531 3539 15337802 10.1200/JCO.2004.08.127 1:CAS:528:DC%2BD2cXpsVWku7s%3D (Pubitemid 41103659)
2. ST Cheung KL Leung YC Ip X Chen DY Fong IO Ng ST Fan S So 2005 Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma Clin Cancer Res 11 2 pt 1 551 556 15701840 1:CAS:528: DC%2BD2MXislWgtL4%3D (Pubitemid 40116879)
3. YL Choi J Kim MJ Kwon JS Choi TJ Kim DS Bae SS Koh YH In YW Park SH Kim G Ahn YK Shin 2007 Expression profile of tight junction protein claudin 3 and claudin 4 in ovarian serous adenocarcinoma with prognostic correlation Histol Histopathol 22 11 1185 1195 17647191 1:CAS:528:DC%2BD2sXhtlaks7nE (Pubitemid 47470312)
4. ST Fan CM Lo CL Liu CM Lam WK Yuen C Yeung J Wong 1999 Hepatectomy for hepatocellular carcinoma: toward zero hospital death Ann Surg 229 3 322 330 10077043 10.1097/00000658-199903000-00004 1:STN:280:DyaK1M7nsVKlsw%3D%3D (Pubitemid 30191766)
5. J He D Gu X Wu K Reynolds X Duan C Yao J Wang CS Chen J Chen RP Wildman MJ Klag PK Whelton 2005 Major causes of death among men and women in China N Engl J Med 353 11 1124 1134 16162883 10.1056/NEJMsa050467 1:CAS:528: DC%2BD2MXhtVWhsbnK (Pubitemid 41317435)
6. GW Huang LY Yang 2002 Metallothionein expression in hepatocellular carcinoma and its clinical significance World J Gastroenterol 8 4 650 653 12174372 1:CAS:528:DC%2BD38XntFeqtro%3D
7. GW Huang LY Yang WQ Lu 2005 Expression of hypoxia-inducible factor 1 alpha and vascular endothelial growth factor in hepatocellular carcinoma: impact on neovascularization and survival World J Gastroenterol 11 11 1705 1708 15786555 1:CAS:528:DC%2BD2MXjvFOrur0%3D
8. GW Huang YM Tao X Ding 2009 Endocan expression correlated with poor survival in human hepatocellular carcinoma Dig Dis Sci 54 2 389 394 18592377 10.1007/s10620-008-0346-3 1:CAS:528:DC%2BD1MXhtlOqtLo%3D
9. C Hubert C Sempoux J Rahier Y Horsmans A Geubel BE Van Beers L Annet F Zech D Leonard JF Giqot 2007 Prognostic risk factors of survival after resection of hepatocellular carcinoma Hepatogastroenterology 54 78 1791 1797 18019720 (Pubitemid 350068480)
10. YC Ip ST Cheung YT Lee JC Ho ST Fan 2007 Inhibition of hepatocellular carcinoma invasion by suppression of claudin- 10 in HLE cells Mol Cancer Ther 6 11 2858 2867 18025272 10.1158/1535-7163.MCT-07-0453 1:CAS:528:DC%2BD2sXhtlWkt7nI (Pubitemid 350206764)
11. J Li S Chigurupati R Agarwal MR Mughal MP Mattson KG Becker WH Wood 3rd Y Zhang PJ Morin 2009 Possible angiogenic roles for claudin-4 in ovarian cancer Cancer Biol Ther 8 19 1814 1822
12. CD Mann CP Neal G Garcea MM Manson AR Dennison DP Berry 2007 Prognostic molecular markers in hepatocellular carcinoma: a systematic review Eur J Cancer 43 6 979 992 17291746 10.1016/j.ejca.2007.01.004 1:CAS:528:DC%2BD2sXjslGnurY%3D (Pubitemid 46483030)
13. K Morita S Tsukita Y Miyachi 2004 Tight junction-associated protein (occludin, ZO-1, claudin-1, claudin-4) in squamous cell carcinoma and Bowen's disease Br J Dermatol 151 2 328 334 15327539 10.1111/j.1365-2133.2004.06029.x 1:CAS:528:DC%2BD2cXoslGlu7s%3D (Pubitemid 39215146)
14. Z Németh AM Szász P Tátrai J Németh H Gyorffy A Somorácz A Szíjártó P Kupcsulik A Kiss Z Schaff 2009 Claudin-1, -2, -3, -4, -7, -8, and-10 protein expression in biliary tract cancers J Histochem Cytochem 57 2 113 121 18854598 10.1369/jhc.2008.952291
15. LS Nichols R Ashfaq CA Iacobuzio-Donahue 2004 Claudin 4 protein expression in primary and metastatic pancreatic caner: support for use as a therapeutic target Am J Clin Pathol 121 2 226 230 14983936 10.1309/ K144PHVDDUPDD401 1:CAS:528:DC%2BD2cXhs1Glt7s%3D (Pubitemid 38140127)
16. LB Rangel R Agarwal T D'Souza ES Pizer PL Alò WD Lancaster L Gregoire DR Schwartz KR Cho PJ Morin 2003 Tight junction proteins claudin-3 and claudin-4 are frequently overexpressed in ovarian cancer but not in ovarian cystadenomas Clin Cancer Res 9 7 2567 2575 12855632 1:CAS:528: DC%2BD3sXlt1yrsrw%3D (Pubitemid 36842098)
17. MB Resnick T Konkin J Routhier E Sabo VE Pricolo 2005 Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study Mod Pathol 18 4 511 518 15475928 10.1038/modpathol.3800301 1:CAS:528:DC%2BD2MXisVSht7Y%3D (Pubitemid 40478114)
18. Y Sanada K Yoshida H Itoh 2007 Comparison of CT enhancement patterns and histologic features in hepatocellular carcinoma up to 2 cm: assessment of malignant potential with claudin-10 immunohistochemistry Oncol Rep 17 5 1177 1182 17390062
19. AD Santin F Zhan S Bellone M Palmieri S Cane E Bignotti S Anfossi M Gokden D Dunn JJ Roman TJ O'Brien E Tian MJ Cannon J Shaughnessy Jr S Pecorelli 2004 Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy Int J Cancer 112 1 14 25 15305371 10.1002/ijc.20408 1:CAS:528:DC%2BD2cXnvVWls7k%3D (Pubitemid 39249487)
20. M Sherman 2008 Recurrence of hepatocellular carcinoma N Engl J Med 359 19 2045 2047 18923166 10.1056/NEJMe0807581 1:CAS:528:DC%2BD1cXhtleis77E
21. M Sugita M Geraci B Gao RL Powell FR Hirsch G Johnson R Lapadat E Gabrielson R Bremnes PA Bunn WA Franklin 2002 Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma Cancer Res 62 14 3971 3979 12124329 1:CAS:528:DC%2BD38XlsV2lsL4%3D (Pubitemid 34791062)
22. AM Tokes J Kulka S Paku A Szik C Páska PK Novák L Szilák A Kiss K Bögi Z Schaff 2005 Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study Breast Cancer Res 7 2 R296 R305 15743508 10.1186/bcr983 1:CAS:528:DC%2BD2MXhslyju7g%3D
23. W Wang LY Yang GW Huang WQ Lu ZL Yang JQ Yang HL Liu 2004 Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis Br J Cancer 90 12 2349 2355 15150600 1:CAS:528: DC%2BD2cXks1ahtr8%3D (Pubitemid 38961899)
24. SM Wang LL Ooi KM Hui 2007 Identification and validation of a novel gene signature associated with the recurrence of human hepatocellular carcinoma Clin Cancer Res 13 21 6275 6283 17975138 10.1158/1078-0432.CCR-06-2236 1:CAS:528:DC%2BD2sXht1Cgtb7L (Pubitemid 350075015)